Effect of Vitamin D on Morbidity and Mortality of the COVID-19
Status:
Recruiting
Trial end date:
2020-12-30
Target enrollment:
Participant gender:
Summary
Patients diagnosed of COVID-19 disease are randomized to receive a single dose of 100.000 IU
of Cholecalciferol (Vitamin D arm) or no vitamin D (on top of the current medication used to
treat COVID 19).
Clinical, radiological and biochemical outcomes of COVID 19 disease as well as mortality are
evaluated.
Phase:
Phase 4
Details
Lead Sponsor:
Fundación para la Investigación Biosanitaria del Principado de Asturias
Collaborators:
Hospital Universitario Central de Asturias Instituto de Investigación Sanitaria del Principado de Asturias